查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702296

2025 年至 2033 年男性不孕症市場報告（按測試類型、治療、配銷通路、最終用戶和地區）

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球男性不孕症市場規模價值 42.1 億美元。展望未來， IMARC Group估計到 2033 年該市場規模將達到 63.2 億美元，2025-2033 年期間的複合年成長率為 4.51%。歐洲目前佔據市場主導地位。男性不孕症盛行率的上升、延遲生育趨勢的出現、顯著的技術進步、生活方式的改變、對不孕症認知的提高以及輔助生殖技術的合法化是推動市場發展的一些主要因素。

男性不孕症是指男性因生殖系統因素導致女性伴侶無法受孕的情況。這通常歸因於精子的產生、品質或輸送問題。導致男性不孕的因素包括精子數量低、精子形狀或活力異常、荷爾蒙失衡、遺傳因素以及某些疾病，如精索靜脈曲張（陰囊靜脈擴張）。過量飲酒、吸煙、吸毒和肥胖等生活方式因素也會導致男性不孕。

全球男性不孕症發病率的上升是推動市場發展的重要因素。生活方式的改變、環境污染物以及與壓力相關的因素加劇了這種擔憂，因此需要診斷和治療方案。此外，為了追求職業目標和其他生活願望而延遲生育的趨勢導致男性與年齡相關的生育問題更加嚴重。這刺激了對男性不孕症治療和輔助生殖技術的需求。除此之外，由於教育活動和數位資源的推動，人們對生育問題的認知不斷提高，促使更多男性尋求醫療協助來解決不孕症問題，從而推動了市場成長。除此之外，久坐的生活方式、不良的飲食習慣以及接觸環境毒素的增加都與精子品質和數量的下降有關。隨著人們越來越意識到這些因素，對抵消這些影響的干涉和治療的需求也隨之增加。同時，醫療技術的進步提高了男性不孕症診斷程序和治療方案的準確性。精子DNA碎片分析和先進的精子選擇方法等創新技術提高了治療效果。

男性不孕症市場趨勢/促進因素：

男性不孕症盛行率不斷上升

久坐的生活方式、接觸環境污染物以及高壓力水平等多種因素共同導致了男性生育問題的增加。這些因素會對精子的產生、品質和活力產生不利影響。隨著人們對男性不孕症盛行率的認知不斷提高，對準確診斷和有效治療方案的需求也日益成長。夫妻正在尋求醫療專業知識來解決這些問題，從而導致生育服務的諮詢和採用增加。

延後生育的趨勢日益明顯

由於社會規範和職業抱負的不斷變化，推遲生育的趨勢日益增強。然而，年齡的成長與男性生育能力的下降有關，包括精子品質下降和 DNA 碎片化增加。這種現象導致了男性因年齡增加而出現生育困難。因此，男性不孕症市場見證了希望晚年建立家庭的老年男性對生育能力保存和治療方案的需求激增。這一趨勢強調了採取專門干預措施以滿足這一人群的獨特需求的必要性。

重大技術進步

精子DNA碎片分析等創新技術可以更全面地評估精子品質。此外，先進的精子選擇方法，例如磁激活細胞分選（MACS），提高了成功受精的機會。這些技術提高了識別不孕症根本原因的準確性，並為醫療保健專業人員提供了更廣泛的工具來製定治療計劃。隨著技術的不斷發展，它有可能透過為患者提供更有效和個人化的解決方案來顯著改善治療結果並促進男性不孕症市場的成長。

按測試類型分類：

  • 精子凝集試驗
  • DNA片段化技術
  • 氧化壓力分析
  • 電腦輔助精液分析
  • 精子穿透試驗
  • 其他

DNA片段化技術佔市場主導地位

DNA碎片化技術因其能夠對男性不孕症提供更深入的了解，成為按測試類型分類的市場中最大的細分領域。該技術評估精子內的 DNA 損傷，提供有關精子品質的關鍵資訊。因此，它在準確診斷男性不孕症的根本原因、指導個人化治療方法以獲得更好的結果方面發揮了重要作用。

按治療分類：

  • 藥物
  • 輔助生殖技術與精索靜脈曲張手術

輔助生殖技術和精索靜脈曲張手術佔據最大市場佔有率

ART 包括體外受精 (IVF) 和卵胞漿內單一精子注射 (ICSI) 等技術，為夫妻提供了克服各種生育挑戰的機會，包括男性不孕症。 ART 的成功率和進步使其成為領先的選擇。另一方面，精索靜脈曲張手術是一種成熟的治療精索靜脈曲張的手術介入方法，精索靜脈曲張是陰囊內的靜脈擴張，會阻礙精子的產生和品質。透過手術矯正精索靜脈曲張，可以改善血液流動，從而有可能增強精子的產生和活力。該手術在恢復生育能力方面已顯示出積極的成果。這些治療方法之所以受歡迎，是因為它們已被證實有效，從而在市場治療領域中佔據突出地位。

依配銷通路分類：

  • 醫院藥房
  • 藥局和藥局
  • 網路藥局

男性不孕症產品主要透過醫院藥局銷售

醫院提供一系列專業的診斷設施、醫療專業知識和治療方案。這使得它們成為尋求全面評估、生育專家諮詢以及先進干預措施（包括輔助生殖技術 (ART) 和外科手術）的患者的主要目的地。藥局透過提供支持男性生殖健康的處方藥、補充劑和生育相關產品發揮至關重要的作用。它們為患者提供了獲取生育治療和管理處方藥的便捷途徑。此外，藥局提供了一個謹慎的環境，個人可以在這裡獲得非處方生育補充劑和補充治療計劃的產品。

按最終用戶分類：

  • 醫院和診所
  • 生育中心
  • 研究機構
  • 其他

生育中心佔據了大部分市場佔有率

這些中心致力於為面臨生育挑戰的個人和夫婦提供廣泛的客製化服務。生育中心擁有一支經驗豐富的生殖內分泌學家、泌尿科醫生、胚胎學家和其他專家團隊，他們共同提供先進的診斷評估、個人化治療計劃和輔助生殖技術 (ART)。生育中心的多學科性質使得可以對男性不孕症採取整體治療，包括醫學評估、實驗室分析和創新治療。這些中心提供支持性環境，解決生育困難的情緒和身體方面的問題。擁有最先進的技術、尖端的程序以及對男性生殖健康的全面了解，使得生育中心成為尋求專家指導和成功結果以克服男性不孕症的個人的首選。

按地區分類：

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

歐洲在市場上佔據明顯主導地位

該報告還對所有主要區域市場進行了全面的分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，歐洲佔最大的市場佔有率。

該地區擁有完善的醫療保健基礎設施，包括先進的醫療設施、生育診所和研究機構，能夠有效診斷和治療男性不孕症。此外，社會文化動態的變化提高了人們對生育問題的認知和接受度，促使更多的個人和夫妻尋求醫療介入。歐洲國家也重視生殖健康，並提供全面的醫療保健，使更多人能夠接受生育治療。隨著該地區人口老化，延遲生育變得越來越普遍，對輔助生殖技術（ART）的需求也日益成長。此外，歐洲在醫學研發領域的強大影響力推動了男性不孕症治療的創新，吸引了國內外尋求尖端解決方案的患者。

競爭格局：

領先的公司正在大力投資研發，以創造新的和改進的男性不孕症診斷工具、治療方法和技術。這包括開發創新的精子分析技術、藥物和輔助生殖技術以提高治療效果。此外，主要參與者經常與學術機構、研究組織和醫療保健提供者合作，交流知識、分享見解並推動男性不孕症診斷和治療的進步。這些合作促進了應對複雜挑戰和開發全面解決方案的協同方法。除此之外，認知到提高男性不孕意識的重要性，行業領導者積極參與教育活動。他們透過線上平台、研討會和醫療保健專業培訓提供資訊，旨在提高對病情的了解並鼓勵及時干預。此外，主要參與者正在進行策略性擴張，以進入對男性不孕症治療需求不斷成長的新興市場。透過擴大覆蓋範圍，他們旨在為更廣泛的患者群體提供先進的診斷和治療方法。

市場研究報告對市場競爭格局進行了全面的分析。也提供了所有主要公司的詳細資料。市場中的一些主要參與者包括：

  • 男科解決方案
  • CinnaGen公司
  • Halotech DNA
  • SCSA 診斷公司
  • 維特羅萊夫
  • Zydus生命科學有限公司
  • 英塔斯製藥股份有限公司
  • Endo 國際有限公司

最新動態：

男性科學解決方案在男性不孕症領域取得了最新進展，包括對男性因素不孕症的理解和管理的改善。它還致力於開發男性不孕基因面板，在診斷拷貝數變異（CNV）方面​​取得了很高的準確性。這些進步有助於男性不孕症的診斷和治療，從而實現更有效的干涉並改善治療結果。

Halotech DNA 是一家總部位於馬德里的國際領先生物技術公司，推出了用於評估精子品質的創新 DNA 碎片分析系統。這些系統旨在評估精子細胞的 DNA 損傷程度，這可能是導致男性不孕症的因素。此分析有助於確定不孕症的根本原因並指導選擇適當的治療方案。

2022 年，SCSA Diagnostics Inc. 開發了一項名為 SCSA（精子染色質結構分析）的測試，用於評估精子染色質結構和 DNA 鏈斷裂。 SCSA 測試是一種同時進行流式細胞儀測量精子核單股 (ss) 和雙股 (ds) DNA 斷裂程度的雙重方法。該測試透過評估精子 DNA 的完整性提供有關男性不孕症的獨特訊息，這對於成功受精和胚胎發育至關重要。

本報告回答的關鍵問題

  • 男性不孕市場有多大
  • 男性不孕症市場的未來前景如何
  • 推動全球男性不孕症市場的關鍵因素有哪些
  • 哪個地區佔據男性不孕症最大的市場佔有率
  • 全球男性不孕症市場領先的公司有哪些

本報告回答的關鍵問題

  • 男性不孕市場有多大？男性不孕症市場的未來前景如何？
  • 推動全球男性不孕症市場發展的關鍵因素有哪些？
  • 哪個地區佔據男性不孕症最大的市佔率？
  • 全球男性不孕症市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球男性不孕症市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依測試類型

  • 精子凝集試驗
  • DNA片段化技術
  • 氧化壓力分析
  • 電腦輔助精液分析
  • 精子穿透試驗
  • 其他

第7章：市場區隔：依處理方式

  • 藥物
  • 輔助生殖技術與精索靜脈曲張手術

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 藥局和藥局
  • 網路藥局

第9章：市場區隔：依最終用戶

  • 醫院和診所
  • 生育中心
  • 研究機構
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Andrology Solutions
    • CinnaGen Co.
    • Halotech DNA
    • SCSA Diagnostics Inc.
    • Vitrolife
    • Zydus Lifesciences Limited
    • Intas Pharmaceuticals Ltd.
    • Endo International plc
Product Code: SR112025A6416

The global male infertility market size was valued at USD 4.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 6.32 Billion by 2033, exhibiting a CAGR of 4.51% during 2025-2033. Europe currently dominates the market. The rise in the prevalence of male infertility, emerging trend of delayed parenthood, notable technological advancements, changing lifestyles, increasing awareness about infertility, and legalization of assisted reproductive technologies are some of the major factors propelling the market.

Male infertility refers to the condition in which a man is unable to impregnate a female partner due to factors related to his reproductive system. It is often attributed to issues with sperm production, quality, or delivery. Factors that can contribute to male infertility include low sperm count, abnormal sperm shape or motility, hormonal imbalances, genetic factors, and certain medical conditions like varicocele (enlarged veins in the scrotum). Lifestyle factors such as excessive alcohol consumption, smoking, drug use, and obesity can also play a role in male infertility.

The rising incidence of male infertility worldwide is a significant driver for the market. Changing lifestyles, environmental pollutants, and stress-related factors contribute to this growing concern, necessitating the need for diagnostic and treatment solutions. Additionally, the trend of delaying parenthood to pursue career goals and other life aspirations has led to higher age-related fertility issues among men. This has spurred the demand for male infertility treatments and assisted reproductive technologies. Other than this, increasing awareness about fertility issues, thanks to educational campaigns and digital resources, has prompted more men to seek medical assistance for infertility problems, thus driving the market growth. Besides this, sedentary lifestyles, poor dietary habits, and increased exposure to environmental toxins have been linked to declining sperm quality and quantity. As individuals become more conscious of these factors, the demand for interventions and treatments to counteract these effects has risen. In line with this, advancements in medical technologies have improved the accuracy of diagnostic procedures and treatment options for male infertility. Innovative techniques such as sperm DNA fragmentation analysis and advanced sperm selection methods have enhanced treatment outcomes.

Male Infertility Market Trends/Drivers:

Increasing Prevalence of Male Infertility

A multitude of factors, including sedentary lifestyles, exposure to environmental pollutants, and high stress levels, have collectively contributed to a rise in fertility issues among men. These factors can adversely affect sperm production, quality, and motility. As the prevalence of male infertility becomes more recognized, there is a growing demand for accurate diagnostics and effective treatment options. Couples are seeking medical expertise to address these concerns, leading to increased consultations and adoption of fertility services.

Rising Trend of Delayed Parenthood

The trend of delaying parenthood has gained momentum due to evolving societal norms and career aspirations. However, advancing age is associated with a decline in male fertility, including decreased sperm quality and increased DNA fragmentation. This phenomenon has given rise to age-related fertility challenges among men. As a result, the male infertility market is witnessing a surge in demand for fertility preservation and treatment options among older men who wish to start families later in life. This trend emphasizes the need for specialized interventions that cater to the unique requirements of this demographic.

Significant Technological Advancements

Innovative techniques such as sperm DNA fragmentation analysis enable a more comprehensive assessment of sperm quality. Additionally, advanced sperm selection methods, such as magnetic-activated cell sorting (MACS), enhance the chances of successful fertilization. These technologies offer improved accuracy in identifying underlying causes of infertility and provide healthcare professionals with a wider range of tools to tailor treatment plans. As technology continues to evolve, it has the potential to significantly improve outcomes and contribute to the growth of the male infertility market by providing patients with more effective and personalized solutions.

Breakup by Test Type:

  • Sperm Agglutination
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

DNA fragmentation technique dominates the market

The DNA fragmentation technique stands as the largest segment in the market breakup by test type due to its ability to offer deeper insights into male infertility. This technique assesses DNA damage within sperm, providing crucial information about sperm quality. As a result, it has gained prominence in accurately diagnosing the underlying causes of male infertility, guiding tailored treatment approaches for better outcomes.

Breakup by Treatment:

  • Medication
  • Assisted Reproductive Technology and Varicocele Surgery

Assisted reproductive technology and varicocele surgery hold the largest market share

ART, encompassing techniques like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), offers couples the opportunity to overcome various fertility challenges, including male factor infertility. The success rates and advancements in ART have positioned it as a leading choice. Varicocele surgery, on the other hand, is a well-established surgical intervention to treat varicoceles, which are dilated veins in the scrotum that can impede sperm production and quality. By surgically correcting varicoceles, blood flow is improved, potentially enhancing sperm production and motility. This procedure has demonstrated positive outcomes in restoring fertility potential. The popularity of these treatments arises from their proven efficacy, leading to their prominent status in the market's treatment landscape.

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Pharmacies and Drug Stores
  • Online Pharmacies

Male infertility products are majorly distributed through hospital pharmacies

Hospitals offer a range of specialized diagnostic facilities, medical expertise, and treatment options under one roof. This makes them a primary destination for patients seeking comprehensive evaluation, consultations with fertility specialists, and advanced interventions, including assisted reproductive technologies (ART) and surgical procedures. Pharmacies play a crucial role by providing access to prescription medications, supplements, and fertility-related products that support male reproductive health. They serve as convenient points of access for patients to obtain prescribed medications for fertility treatment and management. Additionally, pharmacies offer a discreet environment where individuals can access over-the-counter fertility supplements and products that complement treatment plans.

Breakup by End User:

  • Hospitals and Clinics
  • Fertility Centers
  • Research Institutes
  • Others

Fertility centers account for the majority of the share in the market

These centers are dedicated to providing a wide range of services specifically tailored to individuals and couples facing fertility challenges. Fertility centers house a team of experienced reproductive endocrinologists, urologists, embryologists, and other specialists who collectively offer advanced diagnostic evaluations, personalized treatment plans, and assisted reproductive technologies (ART) under one roof. The multidisciplinary nature of fertility centers allows for a holistic approach to male infertility, encompassing medical assessments, laboratory analyses, and innovative treatments. These centers offer a supportive environment that addresses the emotional and physical aspects of fertility struggles. The availability of state-of-the-art technologies, cutting-edge procedures, and a comprehensive understanding of male reproductive health positions fertility centers as the preferred choice for individuals seeking expert guidance and successful outcomes in their journey towards overcoming male infertility.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Europe exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest market share.

The region possesses a well-developed healthcare infrastructure, including advanced medical facilities, fertility clinics, and research institutions, enabling efficient diagnosis and treatment of male infertility. Moreover, changing socio-cultural dynamics have led to increased awareness and acceptance of fertility issues, prompting more individuals and couples to seek medical intervention. European countries also prioritize reproductive health and offer comprehensive healthcare coverage, making fertility treatments more accessible to a larger population. The aging population across the region contributes to a growing demand for assisted reproductive technologies (ART) as delayed parenthood becomes more common. Furthermore, the strong presence of Europe in medical research and development fuels innovations in male infertility treatments, attracting both domestic and international patients seeking cutting-edge solutions.

Competitive Landscape:

Leading companies are investing significantly in research and development to create new and improved diagnostic tools, treatments, and technologies for male infertility. This includes developing innovative sperm analysis techniques, medications, and assisted reproductive technologies to enhance treatment outcomes. Additionally, key players often collaborate with academic institutions, research organizations, and healthcare providers to exchange knowledge, share insights, and drive advancements in male infertility diagnostics and treatments. These collaborations foster a synergistic approach to tackling complex challenges and developing comprehensive solutions. Other than this, recognizing the importance of raising awareness about male infertility, industry leaders are actively involved in educational initiatives. They offer information through online platforms, seminars, and healthcare professional training, aimed at increasing understanding of the condition and encouraging timely interventions. Moreover, key players engage in strategic expansion efforts to tap into emerging markets with growing demand for male infertility treatments. By extending their reach, they aim to provide access to advanced diagnostics and therapies to a wider patient population.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Andrology Solutions
  • CinnaGen Co.
  • Halotech DNA
  • SCSA Diagnostics Inc.
  • Vitrolife
  • Zydus Lifesciences Limited
  • Intas Pharmaceuticals Ltd.
  • Endo International plc.

Recent Developments:

Andrology Solutions has made recent advancements in the field of male infertility, including improvements in the understanding and management of male factor infertility. It has also worked on developing panels for male infertility genes, which have achieved high accuracy in diagnosing copy number variants (CNVs). These advancements contribute to the diagnosis and treatment of male infertility, allowing for more effective interventions and improved outcomes.

Halotech DNA, a leading international biotech company based in Madrid, has introduced innovative DNA fragmentation analysis systems for evaluating sperm quality. These systems are designed to assess the level of DNA damage in sperm cells, which can be a contributing factor to male infertility. This analysis helps in identifying the underlying causes of infertility and guides the selection of appropriate treatment options.

In 2022, SCSA Diagnostics Inc. developed a test called the SCSA (Sperm Chromatin Structure Assay), which is used to evaluate sperm chromatin structure and DNA strand breaks. The SCSA test is a two-fold simultaneous flow cytometry measure of the extent of sperm nuclear single (ss) and double (ds) strand DNA breaks. This test provides unique information about male infertility by assessing the integrity of sperm DNA, which is crucial for successful fertilization and embryo development.

Key Questions Answered in This Report

  • 1.How big is the male infertility market?
  • 2.What is the future outlook of the male infertility market?
  • 3.What are the key factors driving the global male infertility market?
  • 4.Which region accounts for the largest male infertility market share?
  • 5.Which are the leading companies in the global male infertility market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Male Infertility Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Sperm Agglutination
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DNA Fragmentation Technique
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidative Stress Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Computer Assisted Semen Analysis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Sperm Penetration Assay
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Treatment

  • 7.1 Medication
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Assisted Reproductive Technology and Varicocele Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Fertility Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Andrology Solutions
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 CinnaGen Co.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Halotech DNA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 SCSA Diagnostics Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Vitrolife
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Zydus Lifesciences Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Intas Pharmaceuticals Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Endo International plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Male Infertility Market: Major Drivers and Challenges
  • Figure 2: Global: Male Infertility Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Male Infertility Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Male Infertility Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: Male Infertility Market: Breakup by Treatment (in %), 2024
  • Figure 6: Global: Male Infertility Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Male Infertility Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Male Infertility Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Male Infertility (Sperm Agglutination) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Male Infertility (Sperm Agglutination) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Male Infertility (DNA Fragmentation Technique) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Male Infertility (DNA Fragmentation Technique) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Male Infertility (Oxidative Stress Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Male Infertility (Oxidative Stress Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Male Infertility (Computer Assisted Semen Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Male Infertility (Computer Assisted Semen Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Male Infertility (Sperm Penetration Assay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Male Infertility (Sperm Penetration Assay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Male Infertility (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Male Infertility (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Male Infertility (Medication) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Male Infertility (Medication) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Male Infertility (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Male Infertility (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Male Infertility (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Male Infertility (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Male Infertility (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Male Infertility (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Male Infertility (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Male Infertility (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Male Infertility (Fertility Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Male Infertility (Fertility Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Male Infertility (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Male Infertility (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Male Infertility (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Male Infertility (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: North America: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: United States: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: United States: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Canada: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Canada: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia-Pacific: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia-Pacific: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: China: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: China: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Japan: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Japan: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: India: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: India: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: South Korea: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: South Korea: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Australia: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Australia: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Indonesia: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Indonesia: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Europe: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Europe: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Germany: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Germany: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: France: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: France: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: United Kingdom: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: United Kingdom: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Italy: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Italy: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Spain: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Spain: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Russia: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Russia: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Latin America: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Latin America: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Brazil: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Brazil: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Mexico: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Mexico: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Middle East and Africa: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Middle East and Africa: Male Infertility Market: Breakup by Country (in %), 2024
  • Figure 87: Middle East and Africa: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Male Infertility Industry: SWOT Analysis
  • Figure 89: Global: Male Infertility Industry: Value Chain Analysis
  • Figure 90: Global: Male Infertility Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Male Infertility Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Male Infertility Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 3: Global: Male Infertility Market Forecast: Breakup by Treatment (in Million USD), 2025-2033
  • Table 4: Global: Male Infertility Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Male Infertility Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Male Infertility Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Male Infertility Market: Competitive Structure
  • Table 8: Global: Male Infertility Market: Key Players